Use of serotonin reuptake inhibitors in patients with psoriasis is associated with a decreased need for systemic psoriasis treatment: A population-based cohort study

Journal of Internal Medicine

Volumn 274, Issue 3, 2013, Pages 281-287

  Thorslund, K ^a   Svensson, T ^a   Nordlind, K ^a   Ekbom, A ^a   Fored, C M ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cohort study; Psoriasis; Serotonin reuptake inhibitors

Indexed keywords

CITALOPRAM; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCHOOL CHILD; PRESCRIPTION; PRIORITY JOURNAL; PSORIASIS; SCHOOL CHILD; SWEDEN;

COHORT STUDY; PSORIASIS; SEROTONIN REUPTAKE INHIBITORS;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PSORIASIS; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; SWEDEN; TREATMENT OUTCOME;

EID: 84881550489     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/joim.12093     Document Type: Article

References (22)

1. Gudjonsson JE, Elder JT. Psoriasis: epidemiology. Clin Dermatol 2007; 25: 535-46.
2. Kurd SK, Troxel AB, Crits-Christoph P, Gelfand JM. The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study. Arch Dermatol 2010; 146: 891-5.
3. Verhoeven EW, Kraaimaat FW, de Jong EM, Schalkwijk J, van de Kerkhof PC, Evers AW. Individual differences in the effect of daily stressors on psoriasis: a prospective study. Br J Dermatol 2009; 161: 295-9.
4. Luis Blay S. Depression and psoriasis comorbidity. Treatment with paroxetine: two case reports. Ann Clin Psychiatry 2006; 18: 271-2.
5. Hemlock C, Rosenthal JS, Winston A. Fluoxetine-induced psoriasis. Ann Pharmacother 1992; 26: 211-2.
6. Osborne SF, Stafford L, Orr KG. Paroxetine-associated psoriasis. Am J Psychiatry 2002; 159: 2113.
7. Tan Pei Lin L, Kwek SK. Onset of psoriasis during therapy with fluoxetine. Gen Hosp Psychiatry 2010; 32: 446. e9-e10.
8. Sacre S, Medghalchi M, Gregory B, Brennan F, Williams R. Fluoxetine and citalopram exhibit potent anti-inflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors. Arthritis Rheum 2010; 62: 683-93.
9. Thorslund K, El-Nour H, Nordlind K. The serotonin transporter protein is expressed in psoriasis, where it may play a role in regulating apoptosis. Arch Dermatol Res 2009; 301: 449-57.
10. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-7.
11. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol 2009; 24: 659-67.
12. Socialstyrelsen. Kvalitet och innehåll i patientregistret. http://www.socialstyrelsen.se/publikationer2009/2009-125-15, 2009.
13. WHO. International Classification of Diseases (ICD) World Health Organization (Website). 2011 [cited 1st March 2011]; Available from: http://www.who.int/classifications/icd/en/.
14. Wettermark B, Hammar N, Fored CM et al. The new Swedish Prescribed Drug Register-opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf 2007; 16: 726-35.
15. WHO. Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology (Website). 2011 [cited 6th June 2011]; Available from: http://www.whocc.no/.
16. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-41.
17. Gelfand JM, Shin DB, Neimann AL, Wang X, Margolis DJ, Troxel AB. The risk of lymphoma in patients with psoriasis. J Invest Dermatol 2006; 126: 2194-201.
18. Gelfand JM, Troxel AB, Lewis JD et al. The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007; 143: 1493-9.
19. Ahlehoff O, Skov L, Gislason G et al. Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study. J Intern Med 2013; 273: 197-204.
20. Diamond M, Kelly JP, Connor TJ. Antidepressants suppress production of the Th1 cytokine interferon-gamma, independent of monoamine transporter blockade. Eur Neuropsychopharmacol 2006; 16: 481-90.
21. Li XQ, Wang HM, Yang CG, Zhang XH, Han DD, Wang HL. Fluoxetine inhibited extracellular matrix of pulmonary artery and inflammation of lungs in monocrotaline-treated rats. Acta Pharmacol Sin 2011; 32: 217-22.
22. Praschak-Rieder N, Willeit M, Wilson AA, Houle S, Meyer JH. Seasonal variation in human brain serotonin transporter binding. Arch Gen Psychiatry 2008; 65: 1072-8.